[go: up one dir, main page]

NO20030397L - Amyloid målsökende billeddannende midler og anvendelser av samme - Google Patents

Amyloid målsökende billeddannende midler og anvendelser av samme

Info

Publication number
NO20030397L
NO20030397L NO20030397A NO20030397A NO20030397L NO 20030397 L NO20030397 L NO 20030397L NO 20030397 A NO20030397 A NO 20030397A NO 20030397 A NO20030397 A NO 20030397A NO 20030397 L NO20030397 L NO 20030397L
Authority
NO
Norway
Prior art keywords
same
imaging agents
targeting imaging
amyloid targeting
amyloid
Prior art date
Application number
NO20030397A
Other languages
English (en)
Other versions
NO20030397D0 (no
Inventor
Francine Gervais
Xianqi Kong
Robert Chalifour
David Migneault
Original Assignee
Neurochem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurochem Inc filed Critical Neurochem Inc
Publication of NO20030397D0 publication Critical patent/NO20030397D0/no
Publication of NO20030397L publication Critical patent/NO20030397L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20030397A 2000-07-25 2003-01-24 Amyloid målsökende billeddannende midler og anvendelser av samme NO20030397L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22080800P 2000-07-25 2000-07-25
US09/915,092 US20020115717A1 (en) 2000-07-25 2001-07-24 Amyloid targeting imaging agents and uses thereof
PCT/CA2001/001071 WO2002007781A2 (en) 2000-07-25 2001-07-25 Amyloid targeting imaging agents and uses thereof

Publications (2)

Publication Number Publication Date
NO20030397D0 NO20030397D0 (no) 2003-01-24
NO20030397L true NO20030397L (no) 2003-03-24

Family

ID=26915211

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030397A NO20030397L (no) 2000-07-25 2003-01-24 Amyloid målsökende billeddannende midler og anvendelser av samme

Country Status (6)

Country Link
US (1) US20020115717A1 (no)
EP (1) EP1303311A2 (no)
AU (1) AU2001278319A1 (no)
CA (1) CA2416617A1 (no)
NO (1) NO20030397L (no)
WO (1) WO2002007781A2 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1237547A2 (en) * 1999-07-09 2002-09-11 Isis Innovation Limited Compounds for inhibiting diseases and preparing cells for transplantation
AU2002251682A1 (en) * 2000-11-02 2002-08-28 Cornell Research Foundation, Inc. In vivo multiphoton diagnostic detection and imaging of a neurodegenerative disease
US20040049134A1 (en) * 2002-07-02 2004-03-11 Tosaya Carol A. System and methods for treatment of alzheimer's and other deposition-related disorders of the brain
DE10230141B4 (de) * 2002-07-04 2004-07-15 Priontype Gmbh Verfahren und Kit zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc)
WO2004064869A2 (en) * 2003-01-22 2004-08-05 The General Hospital Corporation Amyloid-binding, metal-chelating agents
BRPI0411743A (pt) * 2003-06-23 2006-08-08 Neurochem Int Ltd método e composições para tratar doenças relacionadas a amilóides
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US20050214222A1 (en) * 2004-02-13 2005-09-29 Mckinnon Stuart J In vivo imaging of amyloid plaques in glaucoma using intravenous injectable dyes
WO2006026184A2 (en) * 2004-08-20 2006-03-09 Washington University Blood brain barrier permeation peptides
EP1828111A2 (en) * 2004-11-12 2007-09-05 Neurochem (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
US8044100B2 (en) 2004-12-22 2011-10-25 Bellus Health Inc. Methods and compositions for treating amyloid-related diseases
WO2006110621A2 (en) * 2005-04-11 2006-10-19 Cornell Research Foundation, Inc. Multiplexed biomarkers for monitoring the alzheimer's disease state of a subject
TW200716088A (en) * 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
US20070049638A1 (en) * 2005-07-21 2007-03-01 Neurochem (International) Limited Polymorphic forms of 3-amino-1-propanesulfonic acid
CN101453999A (zh) * 2005-12-22 2009-06-10 神经化学（国际）有限公司 肾病症、糖尿病肾病和血脂异常的治疗
EP2862581B1 (en) 2006-10-12 2021-08-11 BHI Limited Partnership Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
CA2673022A1 (en) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
SI2247558T2 (sl) 2008-02-14 2024-10-30 Eli Lilly And Company Nova kontrastna sredstva za zaznavanje nevroloških disfunkcij
JPWO2010087315A1 (ja) * 2009-01-29 2012-08-02 株式会社林原生物化学研究所 抗アルツハイマー病剤
JP5591720B2 (ja) * 2009-01-29 2014-09-17 株式会社林原 抗神経変性疾患剤
WO2010087313A1 (ja) * 2009-01-29 2010-08-05 株式会社林原生物化学研究所 神経突起伸展促進剤
US9023767B2 (en) * 2009-05-07 2015-05-05 Memorial Sloan-Kettering Cancer Center γ-Secretase substrates and methods of use
CN103502466A (zh) 2010-09-07 2014-01-08 斯隆－凯特林纪念癌症中心 用于γ-分泌酶测定的方法和组合物
US9683017B2 (en) 2014-07-17 2017-06-20 University Tennessee Research Foundation Inhibitory peptides of viral infection
EP3186273A4 (en) 2014-08-26 2018-05-02 University of Tennessee Research Foundation Targeting immunotherapy for amyloidosis
US10493172B2 (en) 2016-06-02 2019-12-03 California Institute Of Technology Gas-filled structures and related compositions, methods and systems to image a target site
US11118210B2 (en) 2016-07-28 2021-09-14 California Institute Of Technology Genetically engineered gas vesicle gene clusters, genetic circuits, vectors, prokaryotic cells, compositions, methods and systems for contrast-enhanced imaging
WO2020146379A1 (en) 2019-01-07 2020-07-16 California Institute Of Technology Gas vesicle expression systems, gas vesicle constructs and related genetic circuits, vectors, mammalian cells, hosts, compositions, methods and systems
WO2020146367A1 (en) 2019-01-07 2020-07-16 California Institute Of Technology Burst ultrasound reconstruction with signal templates and related methods and systems
US11446523B2 (en) * 2019-03-28 2022-09-20 California Institute Of Technology Compositions, methods and systems for gas vesicle based cavitation
CN111398465B (zh) * 2020-04-03 2021-08-10 北京先通国际医药科技股份有限公司 一种pet显像剂前体fcpha及其顺式异构体的测定方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840294A (en) * 1993-03-29 1998-11-24 Queen's University At Kingston Method for treating amyloidosis
WO1997041856A1 (en) * 1996-05-08 1997-11-13 Massachusetts Institute Of Technology ORGANOMETALLIC LIGANDS FOR THE LOCALIZATION AND QUANTIFICATION OF AMYLOID IN VIVO AND $i(IN VITRO)
US6261537B1 (en) * 1996-10-28 2001-07-17 Nycomed Imaging As Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
IL149924A0 (en) * 1999-11-29 2002-11-10 Neurochem Inc Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
WO2001087354A2 (en) * 2000-05-17 2001-11-22 Bristol-Myers Squibb Pharma Company Use of small molecule radioligands for diagnostic imaging
US6589504B1 (en) * 2000-09-22 2003-07-08 Pharmacia & Upjohn Company Compounds and methods for diagnosing and treating amyloid-related conditions

Also Published As

Publication number Publication date
CA2416617A1 (en) 2002-01-31
NO20030397D0 (no) 2003-01-24
WO2002007781A2 (en) 2002-01-31
EP1303311A2 (en) 2003-04-23
US20020115717A1 (en) 2002-08-22
WO2002007781A3 (en) 2002-10-31
AU2001278319A1 (en) 2002-02-05

Similar Documents

Publication Publication Date Title
NO20030397D0 (no) Amyloid målsökende billeddannende midler og anvendelser av samme
DE60113409D1 (de) Kombinierte impedanzbildgebung und mammographie
EE200200550A (et) Karbamaatsed kaspaasi inhibiitorid ja nende kasutamine
DE60131227D1 (de) Toner und Bildherstellungsverfahren
ID30590A (id) Celana sekali pakai jenis-celana pendek
AR027938A1 (es) Compuestos uracilo y utilizacion de los mismos
DE50112013D1 (de) Deodorantien und antiperspirantien
EP1412378A4 (en) APTAMERES AND ANTIAPTAMERS
NO20031407L (no) Glukopyranosyloksybenzylbenzen-derivater og medisinske sammensetninger inneholdende det samme
NO20022656D0 (no) Caspaseinhibitorer og anvendelse derav
ATE450663T1 (de) Verschleissteil und -anordnung
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
DK1370128T3 (da) Kombineret ballepresse og ballevikler
NO20005440L (no) Pakkebaserte personlig utstyrsarrangementer og - fremgangsmåter
NO20025158D0 (no) Lipidpreparat og anvendelse derav
PT1390516E (pt) Novos vectores de expressão e uso dos mesmos
DE60120291D1 (de) Endoskop und Endoskopkapsel
NO20023737L (no) Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
PL360839A1 (pl) Zastosowanie szczepów owczych parapoksywirusów przeciw zwłóknieniu narządów
PT1392670E (pt) Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina
NO20032821D0 (no) Sea-trosy og beslektede fremgangsmåter
PT1267621E (pt) Composicoes e metodos herbicidas sinergeticos
NO20034785L (no) Farmas degree ytiske kombinasjoner basert på pyridoindolonderivater og anticancer-midler
DE60219418D1 (de) Silanylphenole und -naphthole

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application